{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:50:36Z","timestamp":1785480636047,"version":"3.56.0"},"reference-count":28,"publisher":"BMJ","issue":"19","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"OMRON Healthcare, Co., Ltd., Kyoto, Japan","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2024,4,28]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Heart failure (HF) is characterised by collagen deposition. Urinary proteomic profiling (UPP) followed by peptide sequencing identifies parental proteins, for over 70% derived from collagens. This study aimed to refine understanding of the antifibrotic action of spironolactone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this substudy (n=290) to the Heart \u2018Omics\u2019 in Ageing Study trial, patients were randomised to usual therapy combined or not with spironolactone 25\u201350\u2009mg\/day and followed for 9 months. The analysis included 1498 sequenced urinary peptides detectable in \u226530% of patients and carboxyterminal propeptide of procollagen I (PICP) and PICP\/carboxyterminal telopeptide of collagen I (CITP) as serum biomarkers of COL1A1 synthesis. After rank normalisation of biomarker distributions, between-group differences in their changes were assessed by multivariable-adjusted mixed model analysis of variance. Correlations between the changes in urinary peptides and in serum PICP and PICP\/CITP were compared between groups using Fisher\u2019s Z transform.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Multivariable-adjusted between-group differences in the urinary peptides with error 1 rate correction were limited to 27 collagen fragments, of which 16 were upregulated (7 COL1A1 fragments) on spironolactone and 11 downregulated (4 COL1A1 fragments). Over 9 months of follow-up, spironolactone decreased serum PICP from 81 (IQR 66\u201395) to 75 (61\u201390) \u00b5g\/L and PICP\/CITP from 22 (17\u201328) to 18 (13\u201326), whereas no changes occurred in the control group, resulting in a difference (spironolactone minus control) expressed in standardised units of \u22120.321 (95% CI 0.0007). Spironolactone did not affect the correlations between changes in urinary COL1A1 fragments and in PICP or the PICP\/CITP ratio.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Spironolactone decreased serum markers of collagen synthesis and predominantly downregulated urinary collagen-derived peptides, but upregulated others. The interpretation of these opposite UPP trends might be due to shrinking the body-wide pool of collagens, explaining downregulation, while some degree of collagen synthesis must be maintained to sustain vital organ functions, explaining upregulation. Combining urinary and serum fibrosis markers opens new avenues for the understanding of the action of antifibrotic drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02556450\">NCT02556450<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323796","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:50:13Z","timestamp":1715305813000},"page":"1180-1187","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial"],"prefix":"10.1136","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct02556450","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02556450","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-3770","authenticated-orcid":false,"given":"Yu-Ling","family":"Yu","sequence":"first","affiliation":[{"name":"Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium"},{"name":"Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Siwy","sequence":"additional","affiliation":[{"name":"Mosaiques-Diagnostics GmbH, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Wei","family":"An","sequence":"additional","affiliation":[{"name":"Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium"},{"name":"Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium"},{"name":"Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-6528","authenticated-orcid":false,"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Hansen","sequence":"additional","affiliation":[{"name":"Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium"},{"name":"Steno Diabetes Center Copenhagen, the Capital Region of Denmark, Gentofte, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Latosinska","sequence":"additional","affiliation":[{"name":"Mosaiques-Diagnostics GmbH, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-0464","authenticated-orcid":false,"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d\u2019Investigation Clinique Plurith\u00e9matique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ravassa","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Mariottoni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cortona Hospital, Arezzo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-1298","authenticated-orcid":false,"given":"Job AJ","family":"Verdonschot","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fozia","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Petutschnigg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charit\u00e9 University Medicine Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Partner Site Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d\u2019Investigation Clinique Plurith\u00e9matique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Heymans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe J","family":"Cuthbert","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, East Riding of Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d\u2019Investigation Clinique Plurith\u00e9matique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8362-668X","authenticated-orcid":false,"given":"Andrew L","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, East Riding of Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[{"name":"Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim S","family":"Nawrot","sequence":"additional","affiliation":[{"name":"Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium"},{"name":"Centre for Environmental Sciences, Hasselt University, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Janssens","sequence":"additional","affiliation":[{"name":"Research Unit Cardiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-7016","authenticated-orcid":false,"given":"John G","family":"Cleland","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d\u2019Investigation Clinique Plurith\u00e9matique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Diez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[{"name":"Mosaiques-Diagnostics GmbH, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d\u2019Investigation Clinique Plurith\u00e9matique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France"},{"name":"Cardiovascular R&D Centre UniC@rRISE, Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto Portugal, Porto, Portugal"},{"name":"Portugal % Heart Failure Clinics, Department of Internal Medicine, Centro Hospitalar de Vila Nova de Gaia\/Espinho, Vila Nova de Gaia\/Espinho, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-1637","authenticated-orcid":false,"given":"Jan A","family":"Staessen","sequence":"additional","affiliation":[{"name":"Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium"},{"name":"Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"},{"name":"Biomedical Science Group, University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"2025092023180675000_110.19.1180.1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13300-022-01236-w","article-title":"A Podcast discussing aldosterone and mineralocorticoid antagonists in 2021: a paradigm shift","volume":"13","author":"Epstein","year":"2022","journal-title":"Diabetes Ther"},{"key":"2025092023180675000_110.19.1180.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.06626.x"},{"key":"2025092023180675000_110.19.1180.3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurheartj\/ehaa758","article-title":"The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'Omics' in ageing (HOMAGE) randomized clinical trial","volume":"42","author":"Cleland","year":"2021","journal-title":"Eur Heart J"},{"key":"2025092023180675000_110.19.1180.4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2015.03.046","article-title":"Biomarkers of cardiomyocyte injury and stress identify left atria and left ventricular remodelling and dysfunction: a population-based study","volume":"185","author":"Ravassa","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025092023180675000_110.19.1180.5","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201900091"},{"key":"2025092023180675000_110.19.1180.6","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2666-7568(21)00226-9","article-title":"Urinary peptidomics to address age-related disabilities: a prospective population study with replication in patients","volume":"2","author":"Martens","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"2025092023180675000_110.19.1180.7","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237260","article-title":"Reproducibility evaluation of urinary peptide detection using CE-MS","volume":"26","author":"Mavrogeorgis","year":"2021","journal-title":"Molecules"},{"key":"2025092023180675000_110.19.1180.8","doi-asserted-by":"publisher","DOI":"10.1021\/pr800401m"},{"key":"2025092023180675000_110.19.1180.9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00981"},{"key":"2025092023180675000_110.19.1180.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025092023180675000_110.19.1180.11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ejhf.2394","article-title":"Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spirolacttone effects on left atrial remodelling","volume":"24","author":"Ravassa","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025092023180675000_110.19.1180.12","first-page":"285","article-title":"Statistical estimates and transformed beta-variables","volume":"3","author":"Blom","year":"1961","journal-title":"Biom J"},{"key":"2025092023180675000_110.19.1180.13","doi-asserted-by":"publisher","DOI":"10.1177\/0748730414553029"},{"key":"2025092023180675000_110.19.1180.14","unstructured":"Kleinbaum DG , Kupper LL , Nizam A , et al . The Correlation Coefficient and Straight-Line Regression Analysis. Applied Regression Analysis and Other Multivariate Methods. 4th edn. Andover, Hampshire, UK: BOOKS\/COLE CENGAGE Learning, 2010:91\u2013106."},{"key":"2025092023180675000_110.19.1180.15","unstructured":"Kleinbaum DG , Kupper LL , Nizam A , et al . Straight-Line Regression Analysis. Applied Regression Analysis and Other Multivariate Methods. 4th edn. Andover, Hampshire, UK: BOOKS\/COLE CENGAGE Learning, 2010:41\u201390."},{"key":"2025092023180675000_110.19.1180.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17083-w","article-title":"Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?","volume":"7","author":"Magalh\u00e3es","year":"2017","journal-title":"Sci Rep"},{"key":"2025092023180675000_110.19.1180.17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/toxins14010010","article-title":"Collagen-derived peptides in CKD: a link to fibrosis","volume":"14","author":"Mavrogeorgis","year":"2022","journal-title":"Toxins"},{"key":"2025092023180675000_110.19.1180.18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2023.01.088","article-title":"Spironolactone effect on circulating procollagen type I Carboxy-terminal propeptide: pooled analysis of three randomized trials","volume":"377","author":"Ferreira","year":"2023","journal-title":"Int J Cardiol"},{"key":"2025092023180675000_110.19.1180.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.905"},{"key":"2025092023180675000_110.19.1180.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313731"},{"key":"2025092023180675000_110.19.1180.21","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-313182"},{"key":"2025092023180675000_110.19.1180.22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009693","article-title":"Proteomic analysis of effects of spironolactone in heart failure with preserved ejection fraction","volume":"15","author":"Javaheri","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2025092023180675000_110.19.1180.23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.2579","article-title":"The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial","volume":"24","author":"Kobayashi","year":"2022","journal-title":"European J of Heart Fail"},{"key":"2025092023180675000_110.19.1180.24","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-5-15"},{"key":"2025092023180675000_110.19.1180.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1702750114"},{"key":"2025092023180675000_110.19.1180.26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00855"},{"key":"2025092023180675000_110.19.1180.27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ejhf.3101","article-title":"Effects of empagliflozin on collagen biomarkers in patients with heart failure: findings from the EMPEROR trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025092023180675000_110.19.1180.28","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201800144","article-title":"Urinary Proteomics as a tool to identify kidney responders to Dipeptidyl Peptidase-4 inhibition: a hypothesis-generating analysis of the MERLINA-T2D trial","volume":"13","author":"Siwy","year":"2019","journal-title":"Proteomics Clin Appl"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:18:17Z","timestamp":1758435497000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":28,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,9,16]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/heartjnl-2023-323796"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323796","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}